← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2003 | 71266-2003-2 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5558 | 26436-5558-0 | Nadide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1038 | 1038 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1038 | 1038 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1038 | 1038 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-980 | 69194-980-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1038 | 1038 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0104 | 83863-0104-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1039 | 1039 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5084 | 26436-5084-3 | Biotin 10mg/ml | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1039 | 1039 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1246 | 5446-1246-01 | Methacholine Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1000 | 73271-1000-1 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-401 | 73702-401-02 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6148 | 72196-6148-1 | Magnesium Sulfate Heptahydrate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1039 | 1039 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-009 | 72055-009-01 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6026 | 26436-6026-1 | Nadide | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-028 | 71506-028-59 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1039 | 1039 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1039 | 1039 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-979 | 69194-979-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1039 | 1039 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1040 | 1040 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-973 | 69194-973-10 | 973 VASOPRESSIN 40U/100ML | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1249 | 5446-1249-01 | Methacholine Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-0332 | 71283-0332-3 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0301 | 71285-0301-1 | Magnesium Sulfate Heptahydrate; Dextrose Monohydrate; Trisodium Citrate Dihydrate; Sodium Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8095 | 71285-8095-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-141 | 73702-141-32 | Naloxone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1040 | 1040 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-974 | 69194-974-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1040 | 1040 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-125 | 73702-125-15 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1041 | 1041 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9012 | 83826-9012-3 | Atropine Sulfate Monohydrate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1041 | 1041 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1247 | 5446-1247-01 | Methacholine Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1041 | 1041 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-106 | 73177-106-04 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1041 | 1041 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8096 | 71285-8096-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-002 | 72055-002-01 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5556 | 26436-5556-1 | Naltrexone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1041 | 1041 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1041 | 1041 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-029 | 71506-029-58 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1041 | 1041 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7084 | 71139-7084-2 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1042 | 1042 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-6030 | 83863-6030-1 | Fentanyl Drip 2500 mcg in 50 mL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1042 | 1042 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1241 | 5446-1241-01 | Methacholine Chloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2421 | 72627-2421-1 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-102 | 70324-102-02 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0213 | 71285-0213-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1042 | 1042 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1042 | 1042 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5197 | 26436-5197-1 | Naltrexone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5030 | 70214-5030-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1042 | 1042 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1042 | 1042 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-047 | 71506-047-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1042 | 1042 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7039 | 71285-7039-1 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1043 | 1043 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6176 | 71285-6176-1 | Vancomycin 1.5gm added to NS | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1043 | 1043 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1043 | 1043 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2422 | 72627-2422-1 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-102 | 70324-102-01 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0213 | 71285-0213-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6056 | 71285-6056-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-125 | 71449-125-11 | Neostigmine Methylsulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0724 | 26436-0724-9 | Naltrexone | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6044 | 71285-6044-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1043 | 1043 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1043 | 1043 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-033 | 71506-033-58 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1043 | 1043 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-15 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1044 | 1044 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6084 | 72196-6084-1 | Glycopyrrolate 0.2mg/ml | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-6 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0202 | 71285-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-473 | 76154-473-15 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6057 | 71285-6057-1 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1044 | 1044 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1044 | 1044 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-001 | 71449-001-11 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1045 | 1045 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-909 | 69194-909-01 | 909 LIDOCAINE HCl 4% SYRINGE | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9190 | 71266-9190-1 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0202 | 72196-0202-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Magnesium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0219 | 71285-0219-1 | Mannitol; Lidocaine Hydrochloride; Magnesium Sulfate Heptahydrate; Sodium Bicarbonate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-474 | 76154-474-15 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-474 | 76154-474-15 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-9 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5100 | 71266-5100-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1045 | 1045 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Atropine Sulfate; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-055 | 71506-055-10 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1045 | 1045 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-486 | 70092-486-46 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1046 | 1046 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-037 | 71506-037-58 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:1046 | 1046 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methimazole | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-314 | 69374-314-10 | Midazolam | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0205 | 71285-0205-1 | Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Chloride; Potassium Chloride; Calcium Chloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-475 | 76154-475-15 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-475 | 76154-475-15 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1046 | 1046 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6646 | 71300-6646-3 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1046 | 1046 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1046 | 1046 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1046 | 1046 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-002 | 71506-002-58 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1046 | 1046 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1047 | 1047 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9006 | 83826-9006-5 | Timolol , Brimonidine, Dorzolamide | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methimazole | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0111 | 71285-0111-1 | Mannitol; Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride; Tromethamine; Dextrose Monohydrate; Sodium Acetate; Sodium Gluconate | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-476 | 76154-476-15 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-476 | 76154-476-15 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5066 | 26436-5066-3 | Niacinamide | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6610 | 71300-6610-9 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0903 | 60652-0903-1 | Oxytocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Papaverine Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1047 | 1047 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1047 | 1047 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1048 | 1048 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9017 | 83826-9017-8 | Prednisolone Phosphate, Moxifloxacin HCl, Ketorolac Tromethamine | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Choline Chloride; Inositol | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mechlorethamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Mechlorethamine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-300 | 73463-300-04 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1230 | 73271-1230-1 | Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride; Leucine | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6647 | 71300-6647-9 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5007 | 26436-5007-3 | Panthenol | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5601 | 26436-5601-5 | Phentolamine Mesylate; Papaverine Hydrochloride; Alprostadil | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1048 | 1048 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1048 | 1048 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1049 | 1049 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2554 | 72934-2554-2 | Abenor | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Choline Chloride; Inositol; Benzyl Alcohol | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Midazolam Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-044 | 69389-044-26 | Medroxyprogesterone Acetate | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Megestrol Acetate | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-148 | 63037-148-05 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-148 | 63037-148-05 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2308 | 72934-2308-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6600 | 71300-6600-9 | Naltrexone Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1049 | 1049 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1049 | 1049 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1050 | 1050 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1042 | 73013-1042-1 | Hydromorphone HCl | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Ropivacaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methionine; Choline Chloride; Inositol; Cyanocobalamin; Benzyl Alcohol | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5354 | 26436-5354-1 | Methylene Blue | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-4031 | 71286-4031-2 | Midazolam Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Megestrol Acetate | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Meloxicam | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73463-300 | 73463-300-04 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-785 | 70004-785-40 | Norepinephrine Bitartrate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2429 | 72934-2429-2 | Niacinamide; Tretinoin | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6220 | 72682-6220-1 | Nandrolone Decanoate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:1050 | 1050 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:1050 | 1050 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:1051 | 1051 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6630 | 71300-6630-2 | Gabapentin | 2024-2 | valid | 0 | 2026-09-18 |